Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...